1.
Bioorg Med Chem Lett
; 17(3): 602-8, 2007 Feb 01.
Artículo
en Inglés
| MEDLINE
| ID: mdl-17113292
RESUMEN
We describe the identification of [7-(2,6-dichlorophenyl)-5-methylbenzo [1,2,4]triazin-3-yl]-[4-(2-pyrrolidin-1-ylethoxy)phenyl]amine (3), a potent, orally active Src inhibitor with desirable PK properties, demonstrated activity in human tumor cell lines and in animal models of tumor growth.